Skip to content

In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y.

Oct 2026 · Annals of Internal Medicine · 0 citations · 2 references
Medicine

Abstract

CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Rheumatology: [Formula: see text].

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.